https://www.gov.uk/government/publications/uk-20-year-vision-for-antimicrobial-resistance<\/a><\/p>The 2024 to 2029 AMR NAP is being co-developed across the Government, its agencies, and the administrations in Scotland, Wales, and Northern Ireland, with support from a wide range of external stakeholders, and informed by the responses to the Call for Evidence. The NAP is expected to be published in 2024.<\/p>
The 2024 to 2029 AMR NAP will build on the achievements of the 2019 to 2024 NAP, whilst recognising where there is more to do, and will be aligned with global plans and frameworks for action.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"}
}
, "answeringMemberConstituency" : {"_value" : "Lewes"}
, "answeringMemberPrinted" : {"_value" : "Maria Caulfield"}
, "dateOfAnswer" : {"_value" : "2024-04-23", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-04-23T12:31:44.14Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-04-17", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Antimicrobials: Drug Resistance"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, when she plans to publish the next action plan for antimicrobial resistance.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4488", "label" : {"_value" : "Biography information for Martyn Day"}
}
, "tablingMemberConstituency" : {"_value" : "Linlithgow and East Falkirk"}
, "tablingMemberPrinted" : [{"_value" : "Martyn Day"}
], "uin" : "22343"}
, {"_about" : "http://data.parliament.uk/resources/1694458", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1694458/answer", "answerText" : {"_value" : "
A cross-Government, United Kingdom-wide delivery board monitors and oversees progress in delivering the National Action Plan on antimicrobial resistance (NAP AMR) for 2019 to 2024. The majority of the commitments in the NAP AMR have been assessed as either completed, or as on track for delivery.<\/p>
Progress against the measurable ambitions in the NAP AMR is collated by the UK Health Security Agency, and reported to the delivery board. Significant progress has been made in further reducing antibiotic use in food producing animals, by 59% since 2014, and in humans, with an 8.8% reduction in overall antibiotic usage from 2014 to 2022. Progress has been slower in other areas, such as reducing the incidence of specific drug-resistant infections, due to the diverse nature of the underlying causes of these infections. Other key achievements from the NAP AMR programme over the past five years include:<\/p>
- Piloting innovative ways of evaluating and paying for antibiotics on the National Health Service;<\/p>
- Securing antimicrobial resistance commitments on several ministerial tracks during the UK G7 presidency in 2021; and<\/p>
- £19.2 million investment into One Health Surveillance through the Pathogen Surveillance in Agriculture, Food and Environment Programme.<\/p>
The Department has commissioned the Policy Innovation and Evaluation Research Unit (PIRU) at the London School of Hygiene and Tropical Medicine to conduct an evaluation of the 2019 to 2024 NAP AMR, to inform future policy development and implementation. Findings from the PIRU evaluation will be published following the peer-review process.<\/p>
The forthcoming NAP AMR for 2024 to 2029 is under development, in consultation with a broad range of stakeholders across different sectors, and informed by the findings from the antimicrobial resistance Call for Evidence. This will set us on course for achieving our long-term ambitions, set out in the Government\u2019s 20-year vision to contain, control, and mitigate antimicrobial resistance by 2040.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"}
}
, "answeringMemberConstituency" : {"_value" : "Lewes"}
, "answeringMemberPrinted" : {"_value" : "Maria Caulfield"}
, "dateOfAnswer" : {"_value" : "2024-03-12", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-03-12T12:46:45.96Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-03-07", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Antimicrobials: Drug Resistance"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what progress she has made on delivering the UK 5-year action plan for antimicrobial resistance 2019 to 2024.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4444", "label" : {"_value" : "Biography information for Karin Smyth"}
}
, "tablingMemberConstituency" : {"_value" : "Bristol South"}
, "tablingMemberPrinted" : [{"_value" : "Karin Smyth"}
], "uin" : "17610"}
, {"_about" : "http://data.parliament.uk/resources/1694505", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1694505/answer", "answerText" : {"_value" : "
The Department commissions research through the National Institute for Health and Care Research (NIHR) and welcomes funding applications for research into any aspect of human health, including anti-microbial resistance (AMR).<\/p>
<\/p>
Over the last five years, the NIHR\u2019s programme funding for AMR has totalled £88 million. This includes research that aims to reduce the need for antibiotics, optimising their use and supporting the development of new antimicrobials. This does not include NIHR infrastructure, which is fundamental to supporting all health research.<\/p>
<\/p>
The NIHR has recently launched a competition for new Health Protection Research Units, in partnership with the UK Health Security Agency and academia, which will include multidisciplinary research to inform the prevention and control of AMR.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"}
}
, "answeringMemberConstituency" : {"_value" : "Lewes"}
, "answeringMemberPrinted" : {"_value" : "Maria Caulfield"}
, "dateOfAnswer" : {"_value" : "2024-03-14", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1694505/answer/previousversion/23173", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"}
}
, "answeringMemberConstituency" : {"_value" : "Lewes"}
, "answeringMemberPrinted" : {"_value" : "Maria Caulfield"}
}
, "questionFirstAnswered" : [{"_value" : "2024-03-14T10:38:32.047Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-03-07", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Antimicrobials: Drug Resistance"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps her Department is taking to support research into anti-microbial resistance.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4444", "label" : {"_value" : "Biography information for Karin Smyth"}
}
, "tablingMemberConstituency" : {"_value" : "Bristol South"}
, "tablingMemberPrinted" : [{"_value" : "Karin Smyth"}
], "uin" : "17631"}
, {"_about" : "http://data.parliament.uk/resources/1693079", "AnsweringBody" : [{"_value" : "Foreign, Commonwealth and Development Office"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1693079/answer", "answerText" : {"_value" : "
The High-level Meeting (HLM) on Antimicrobial Resistance (AMR) offers an excellent opportunity to catalyse global progress. The UK's priority is a political declaration that sets a high level of ambition across human health, animal health and environmental sectors. The UK is particularly keen to promote more equitable global access to antimicrobials and their appropriate stewardship.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1547", "label" : {"_value" : "Biography information for Lord Benyon"}
}
, "answeringMemberPrinted" : {"_value" : "Lord Benyon"}
, "dateOfAnswer" : {"_value" : "2024-03-18", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-03-18T17:38:38.383Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "208"}
, "answeringDeptShortName" : {"_value" : "Foreign, Commonwealth and Development Office"}
, "answeringDeptSortName" : {"_value" : "Foreign, Commonwealth and Development Office"}
, "date" : {"_value" : "2024-03-01", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Antimicrobials: Drug Resistance"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask His Majesty's Government what are their priorities ahead of this year's United Nations General Assembly High-level Meeting on Antimicrobial Resistance.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
], "uin" : "HL2935"}
, {"_about" : "http://data.parliament.uk/resources/1693080", "AnsweringBody" : [{"_value" : "Foreign, Commonwealth and Development Office"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1693080/answer", "answerText" : {"_value" : "
The UK's Ending Preventable Deaths campaign takes a multisectoral approach which includes tackling antimicrobial resistance, alongside strengthening health systems, sexual and reproductive health and rights, and broader determinants like nutrition, climate and water, sanitation and hygiene. Neonatal sepsis is a particular concern in the context of antimicrobial resistance and as such is where the UK will look to particularly align our work on water sanitation and hygiene, with our work on antimicrobial resistance and the health of mothers and newborns.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1547", "label" : {"_value" : "Biography information for Lord Benyon"}
}
, "answeringMemberPrinted" : {"_value" : "Lord Benyon"}
, "dateOfAnswer" : {"_value" : "2024-03-15", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-03-15T13:55:41.617Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "208"}
, "answeringDeptShortName" : {"_value" : "Foreign, Commonwealth and Development Office"}
, "answeringDeptSortName" : {"_value" : "Foreign, Commonwealth and Development Office"}
, "date" : {"_value" : "2024-03-01", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Antimicrobials: Drug Resistance"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask His Majesty's Government what steps they are taking to ensure that their approach to tackling antimicrobial resistance across the world also works to end preventable deaths linked to unclean birth environments.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
], "uin" : "HL2936"}
, {"_about" : "http://data.parliament.uk/resources/1693081", "AnsweringBody" : [{"_value" : "Foreign, Commonwealth and Development Office"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1693081/answer", "answerText" : {"_value" : "
Access to water, sanitation and hygiene (WASH) in communities and health care settings helps prevent the threat of antimicrobial resistance. The UK's "WASH Systems for Health" programme is working in six lower-middle-income countries to strengthen the systems that deliver sustainable WASH services. The UK-funded Hygiene and Behaviour Change Coalition supported 14,800 facilities with WASH supplies and trained 460,000 health workers on hygiene. We also focus on achieving universal WASH in health care facilities to combat antimicrobial resistance through partners the World Health Organization (WHO), the United Nations Children's Fund (UNICEF) and the Hand Hygiene for All Partnership.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1547", "label" : {"_value" : "Biography information for Lord Benyon"}
}
, "answeringMemberPrinted" : {"_value" : "Lord Benyon"}
, "dateOfAnswer" : {"_value" : "2024-03-15", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-03-15T13:54:38.263Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "208"}
, "answeringDeptShortName" : {"_value" : "Foreign, Commonwealth and Development Office"}
, "answeringDeptSortName" : {"_value" : "Foreign, Commonwealth and Development Office"}
, "date" : {"_value" : "2024-03-01", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Antimicrobials: Drug Resistance"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask His Majesty's Government what steps they are taking to ensure preventative measures such as enabling access to clean water and basic toilets, and promoting good hygiene practices are central to their work on combatting antimicrobial resistance globally.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
], "uin" : "HL2937"}
, {"_about" : "http://data.parliament.uk/resources/1670097", "AnsweringBody" : [{"_value" : "Department for Environment, Food and Rural Affairs"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1670097/answer", "answerText" : {"_value" : "
Defra, the Environment Agency and the UK Health Security Agency have a joint research programme on antimicrobial resistance in the environment. This includes examination of potential drivers of selection for antimicrobial resistance in environmental organisms. So far, this work has concentrated on the effect of antimicrobials and biocides so has not examined the additional role of microplastics, as this was not identified as likely to have a high impact and therefore be a high priority for the research. However, we continue to consider issues for further investigation as part of our ongoing research where emerging evidence suggests it is needed.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1547", "label" : {"_value" : "Biography information for Lord Benyon"}
}
, "answeringMemberPrinted" : {"_value" : "Lord Benyon"}
, "dateOfAnswer" : {"_value" : "2023-11-30", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2023-11-30T15:23:51.667Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "13"}
, "answeringDeptShortName" : {"_value" : "Environment, Food and Rural Affairs"}
, "answeringDeptSortName" : {"_value" : "Environment, Food and Rural Affairs"}
, "date" : {"_value" : "2023-11-14", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Antimicrobials: Drug Resistance"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask His Majesty's Government what assessment they have made of the combined impacts of microplastics and antimicrobial pollutants in driving antimicrobial resistance emergence in the environment, and what steps they are taking to mitigate these impacts.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
], "uin" : "HL264"}
, {"_about" : "http://data.parliament.uk/resources/1665728", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1665728/answer", "answerText" : {"_value" : "
The UK Health Security Agency (UKHSA) contributes to the World Health Organization\u2019s efforts to address antimicrobial resistance (AMR).<\/p>
<\/p>
The AMR National Action Plan (NAP) 2019-24 highlights the importance of developing new vaccines. The forthcoming NAP (2024-29) is under development, and infection prevention and control, including vaccines, will be a central part of the plan.<\/p>
<\/p>
UKHSA conducts research on the potential for vaccines to tackle antibiotic prescribing and AMR. UKHSA leads work within a European public-private partnership. UKHSA\u2019s AMR network provides innovative technologies and develops interventions to tackle AMR, including vaccines and alternatives to antibiotics.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"}
}
, "answeringMemberConstituency" : {"_value" : "Lewes"}
, "answeringMemberPrinted" : {"_value" : "Maria Caulfield"}
, "dateOfAnswer" : {"_value" : "2023-10-23", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2023-10-23T12:04:15.253Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2023-10-18", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Antimicrobials: Drug Resistance"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of implementing the recommendations of the report by the World Health Organisation entitled Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance, published on 27 January 2023.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4385", "label" : {"_value" : "Biography information for Dr Philippa Whitford"}
}
, "tablingMemberConstituency" : {"_value" : "Central Ayrshire"}
, "tablingMemberPrinted" : [{"_value" : "Dr Philippa Whitford"}
], "uin" : "203319"}
], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&hansardHeading=Antimicrobials%3A+Drug+Resistance", "page" : 0, "startIndex" : 1, "totalResults" : 102, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}